Skip to main content

Table 1 Individual and Overall

From: Dose distribution in the thyroid gland following radiation therapy of breast cancer-a retrospective study

Characteristic Cases Controls
Age1(yrs)   
< 50 3 3
> 50 13 13
Median 56 56
Range 44-75 43-73
Obstime 2 (months)   
< 50 11 12
≥ 50 5 4
Median 44 44
Range 38-56 37-56
Stage   
II 13 13
III 3 3
Surgery 3   
MRM 12 12
BCS 4 4
Chemo 4   
FEC 11 11
other 1 1
No 4 4
Number of Cycles   
6 11 11
4 1 1
Tamoxifen   
yes 15 15
No 1 1
RT (Gy)   
50 Gy 13 13
50+10 Gy 3 3
  1. Radiotherapy, surgical and chemotherapy treatment characteristics for cases (group A) and controls (group B).
  2. 1Age: Age at follow-up
  3. 2Obstime: observation time from breast cancer diagnosis to the outpatient examination
  4. 3Surgery: MRM = Radical mastectomy, BCS = breast conserving surgery
  5. 4Chemotherapy: FEC = (5Fluoro-Uracil, epirubicin, cyclophosfamide), FEC- regimen
  6. Other = 4 cycles of epirubicin
  7. No = no chemotherapy